Chronic Kidney Disease

Chronic kidney disease (CKD) is a progressive condition that prevents the kidneys from working properly, and it affects around 1 in 10 adults worldwide. That’s about 850 million people - roughly the same as the entire population of Europe.

Diabetes and high blood pressure are the leading causes of CKD and together contribute to over half of all CKD-related deaths. CKD doesn’t just affect the kidneys, it can have serious, even fatal, consequences for the heart. People with CKD are at much higher risk of heart failure and other cardiovascular events than those with healthy kidneys. In fact, many people with CKD die from heart-related causes before ever reaching kidney failure.

Beats of Change: Lynn’s story

Protecting your kidneys can protect your heart. Discover why early urine (UACR) testing could save your life.

Early Detection and Chronic Kidney Disease Management

Chronic Kidney Disease is a serious condition that often has no obvious symptoms until it’s advanced. Early detection and management of kidney disease is key to helping protect kidney health.

About Chronic Kidney Disease

Find out more about chronic kidney disease, its causes and symptoms.

Transforming chronic kidney disease treatments to improve connected health

Boehringer Ingelheim's Sandy Sommer on how treatment innovations in CKD can also improve care for connected conditions, including heart failure.

Downloads

Chronic Kidney Disease and its impact on the body

Learn more about chronic kidney disease and how its connected to other organs in the cardiovascular, renal and metabolic system, like the heart.

Other cardiovascular, renal and metabolic diseases

Cardiovascular disease

Cardiovascular diseases are a major global health concern and can increase the risk of developing connected conditions such as chronic kidney disease and type 2 diabetes.

Metabolic diseases

Did you know that type 2 diabetes and obesity affect the metabolic system, and in turn, can impact other organs in the body?

Liver disease

Learn about metabolic dysfunction-associated steatohepatitis (MASH), how it affects the liver and how it is associated with other CRM conditions.